
Vocalis Health: Developing an AI platform for enhanced healthcare solutions.
Vocalis Health, founded with the mission to revolutionize healthcare through artificial intelligence, focuses on developing an AI platform that leverages voice analysis to offer enhanced healthcare solutions. Their core vision is to harness the power of voice biomarkers to provide non-invasive, accessible, and effective health monitoring and diagnostics. The company offers products and services that analyze voice recordings to detect and monitor various health conditions, aiming to improve patient outcomes and streamline clinical workflows. Vocalis Health primarily targets healthcare providers, insurers, and telehealth platforms.
Notable figures associated with Vocalis Health include leading experts in AI and healthcare technology. The company has attracted significant investment from prominent venture capital firms specializing in health tech innovations. Key achievements include successful clinical trials demonstrating the efficacy of their voice-based diagnostic tools and partnerships with major healthcare institutions to integrate their technology into existing systems. Vocalis Health's impact lies in its potential to transform how health conditions are monitored and diagnosed, making healthcare more proactive and personalized.

Canary Speech
canaryspeech.com

Vital Audio
vitalaudio.io

Aiva
aiva.ai

Sonde Health
sondehealth.com

Vocaire
vocaire.ai

Vocxi Health

Aural Analytics
auralanalytics.com

Telling.ai
telling.ai

Bayesian Health
bayesianhealth.com

Videra Health
viderahealth.com

Clinicai

VocoMD

BioAI Health
bioaihealth.com

Clarigent Health

Vocalytics
vocalytics.ai
Companies similar to Vocalis Health include Canary Speech, Vital Audio, Aiva and Sonde Health.
Vocalis Health was founded in 2019.
Vocalis Health's headquarters is located in Boston, MA, US.
Vocalis Health's most recent funding round was for $9M (USD) in December 2019.
As of Dec 12, 2019, Vocalis Health has raised a total of $9M (USD).
Vocalis Health has 26 employees as of Feb 4, 2024.